Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: a multicenter study

MeSH terms

• Adult
• Aged
• Aged, 80 and over
• Disease Progression
• Doxorubicin / analogs & derivatives*
• Doxorubicin / therapeutic use
• Doxorubicin / toxicity
• Female
• Humans
• Male
• Medical Oncology / methods
• Middle Aged
• Polyethylene Glycols / therapeutic use*
• Polyethylene Glycols / toxicity
• Retrospective Studies
• Sarcoma, Kaposi / therapy*
• Treatment Outcome